TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05147831

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning
Description: Place blood pressure cuff around upper, non-dominant arm (e.g. upper left arm in a right-handed patient). Inflate blood pressure cuff to a pressure set at 50 mmHg higher than baseline systolic BP to induce ischemia of arm for 5 minutes. Completely deflate blood pressure cuff to allow for 5 minutes of reperfusion. Subjects would undergo 4 cycles of ischemia and reperfusion,
Study: NCT03708926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abaloparatide
Description: abaloparatide injection pen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo injection pen
Study: NCT05258968

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education on the Injeti Model of Self-Esteem
Description: 1 hour educational session
Study: NCT04895423

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate therapy
Description: Methotrexate subcutaneously 10-15 mg/m2 once every 7 days within 12 months

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil therapy
Description: Mycophenolate mofetil per os 500-700 mg/m2 2 times a day within 12 months

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine therapy
Description: Cyclosporine per os 3 mg/m2 2 times a day within 12 months

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab therapy
Description: Patients weighing \<30 kg received an initial dose of 600 mg (2 injections of 300 mg subcutaneously), then 300 mg every 4 weeks. Patients weighing 30 to \<60 kg received an initial dose of 400 mg (2 injections of 200 mg subcutaneously), then 200 mg every 2 weeks; Patients weighing 60 kg or more, the initial dose is 600 mg (2 injections of 300 mg subcutaneously), then 300 mg every 2 weeks.
Study: NCT05483062

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: galla chinensis
Description: toothpaste

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stannous fluoride
Description: Toothpaste
Study: NCT06344273

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ROM exercises
Description: Each individual in the case group will have lower extremity ROM exercises, each of which will last 20 minutes, at the beginning of the session and at the beginning of the hour until the end of the session.
Study: NCT05097495

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Only NNS
Description: Before the procedure, the Premature Infant Comfort Scale shall be filled out.~Procedure steps for the control group:~* Materials shall be prepared (napkins, non-sterile gloves, pacifier)~* Hands shall be washed; gloves shall be worn.~* The infant shall be given a NNS just before the procedure and continue until the 5th minute after the procedure.~* The diapers shall be changed.~* Hands shall be washed after the procedure.~* The Premature Infant Comfort Scale shall be assessed during, shortly after, and 5 minutes after the procedure.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NNS Combined with Breast Milk
Description: * Before the procedure, the Premature Infant Comfort Scale shall be filled out.~* Materials shall be prepared (napkins, non-sterile gloves, pacifier, breast milk, cup)~* Hands shall be washed; gloves shall be worn.~* The cylindrical part of a pacifier shall be in touch with breast milk for 5 seconds. The infant shall be given the pacifier, combined with breast milk, just before the procedure and continue until the 5th minute after the procedure.~* The diapers shall be changed.~* Hands shall be washed after the procedure.~* The Premature Infant Comfort Scale shall be assessed during, shortly after, and 5 minutes after the procedure.
Study: NCT04949022

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medronic 780G insulin pump
Description: Commercial hybrid closed loop system Medronic 780G
Study: NCT06377267

Intervention type: DRUG
Group type: OTHER
Intervention: Bevacizumab
Description: Bevacizumab dosing is at 15 mg/kg every 3 weeks as an intravenous infusion.
Study: NCT05196191

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIAGENEX Max
Description: Collagenous membrane derived from umbilical cord

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hibiclens wash
Description: Antiseptic skin cleanser
Study: NCT06377267

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab dosing is at 15 mg/kg every 3 weeks as an intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib dosing is oral at 300 mg twice daily
Study: NCT05718492

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: digital subtraction angiography.
Description: Each patient received an artery catheter procedure guided by digital subtraction angiography.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )
Description: Hepatic artery infusion chemotherapy. The FOLFOX (oxaliplatin 130 mg/m2, leucovorin 200 mg/m2, fluorouracil 400 mg/m2, and fluorouracil 2,400 mg/m2) regimen was sequentially infused through the catheter every cycle (3 weeks).
Study: NCT05546177

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: instrumented assisted soft tissue mobilization
Description: The subject will be treated with instrumented assisted soft tissue mobilization, applied to the upper and lower fibers of Pectoral, Trapezius (upper, middle and lower), Rhomboids major , Rhomboids minor, Teres minor, Teres major, and Latissimus dorsi muscles. The IASTM technique was performed for 20 seconds parallel to the muscle fibers followed by 20 seconds perpendicular to the muscle fibers of each one of the selected muscle

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional therapy
Description: the patients will receive Transcutaneous electrical nerve stimulation (TENS) to manage the pain,Ultrasound , Exercise including (Range of motion exercises, stretching exercises, and strengthening exercises (Scapular stabilization exercises and rotator cuff strengthening exercises)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional therapy
Description: the patients will receive Transcutaneous electrical nerve stimulation (TENS) to manage the pain,Ultrasound , Exercise including (Range of motion exercises, stretching exercises, and strengthening exercises (Scapular stabilization exercises and rotator cuff strengthening exercises)
Study: NCT05078658

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Description: The diet will contain age- and gender-specific recommended amount of calories but the amount of carbohydrates would be limited to provide only 15% (+/- 5%) of the recommended energy a day.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Recommended-carbohydrate diet
Description: The subjects will be delivered five pre-made ready meals per day throughout the period (5 weeks). These will contain age- and gender-specific recommended amount of calories with the amount of carbohydrates equal to 45% (+/- 5%) of the recommended energy a day.
Study: NCT06062810

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Crizotinib - Usual
Description: * XALKORI - crizotinib capsule (high dose)~* XALKORI 250 mg taken orally twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Crizotinib - Study
Description: * XALKORI - crizotinib capsule (low dose)~* XALKORI 200 mg taken orally twice daily
Study: NCT06628193

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity focused ultrasound
Description: low-intensity focused ultrasound for neuromodulation applied to the head.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham (No Treatment)
Description: Sham LIFU application
Study: NCT06694025

Intervention type: BIOLOGICAL
Intervention: Efluelda Tetra Pre-filled syringe
Description: Suspension for injection in a pre-filled syringe
Study: NCT06698133

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Participants in the intervention arm will be invited to join a private social media group
Description: Education content
Study: NCT06715761

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release
Description: The sequence of myofascial release is as follows: 30 seconds of contact between the therapist's hands and the entire region of the participant's spine, sliding with medium pressure in a caudocranial direction; palpation of the erector spinae, quadratus lumborum, gluteus and piriformis muscles bilaterally, to identify trigger points, marking each point of tension with a dermographic pencil for subsequent manipulation; 3 cycles of bilateral paravertebral release, by sustained pressure with crossed hands, until the restrictive tissue barrier is found, for 60 seconds; 90 seconds of the vertical rolling technique (superficial elevation of the skin and mobilisation of the tissue with the tips of all the fingers) on the bilateral paravertebrals and, at the end, sliding along the entire length of the bilateral multifidus, with the fingers flexed, using the bony prominence between the proximal and middle phalanges as contact with the skin, in a caudocranial direction and returning craniocaudal.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cupping therapy
Description: The acrylic cups (DongBang®) will be placed on the meridional points, as Traditional Chinese Medicine calls them, 1 cup in the central region of each popliteal fossa, the so-called B40 or Wei Zhong point, 6 cups in the region of the quadratus lumborum muscles, more specifically on the BL23 or Shenshu points (approximately 5 centimetres lateral to the edge of the L2 spinous process), BL24 or Qihaishu (approximately 5 centimetres lateral to the edge of the spinous process of L3) and BL25 or Dachangshu (approximately 5 centimetres lateral to the edge of the spinous process of L4) bilaterally, as well as a cup on a single point of the participant's choice, where they report the most lower back pain (ashi point). The cups will be attached to the skin using a gun, applying two suction pressures, and the participant will be asked to signal whether the pressure is strong or weak. The cups will remain attached for 12 minutes on the B40 meridian and 15 minutes on the other meridians. If a cup lo
Study: NCT06716008

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic training
Description: For twelve weeks, the women in the study group will participate in aerobic training on cycle ergometer. Each session will consist of 30-45 minutes of cycling at a moderate intensity, accompanied by a workout heart rate ranging from 65% to 75% of the maximal heart rate and ranging between 12 and 14 on the Borg rating of perceived exertion 20-point scale. After ten minutes of warm-up, every session will end with a brief 3-minute period of cool-down.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic training
Description: For twelve weeks, the women in the study group will participate in aerobic training on cycle ergometer. Each session will consist of 30-45 minutes of cycling at a moderate intensity, accompanied by a workout heart rate ranging from 65% to 75% of the maximal heart rate and ranging between 12 and 14 on the Borg rating of perceived exertion 20-point scale. After ten minutes of warm-up, every session will end with a brief 3-minute period of cool-down.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual Diaphragm Release
Description: The participant will assume a supine position with relaxed limbs. The therapist should position themselves at the head of the participant and make manual contact with the pisiform, hypothenar region, and the last three fingers on both sides, underneath the seventh to tenth rib costal cartilages. The therapist's forearms should be aligned towards the participant's shoulders. During the inspiratory phase, the therapist gently pulled the points of contact with both hands in the direction of the head and slightly laterally, accompanying the elevation of the ribs. Therapist progressively increases the depth of their contact within the costal margin.
Study: NCT06724822

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RF Vapor Ablation
Description: RF Vapor ablation of the duodenum
Study: NCT06724679

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Utilisability of an immersive VR device in a functional restoration program (FRP) for patients with chronic low back pain.
Description: Patients participating will engage in three 20-minute VR sessions per week, in addition to the standard FRP program, for a duration of four to five weeks. The sessions will consist of a series of pre-programmed exercises designed to facilitate various trunk movements (flexion, extension, inclination, rotation) through exergames. Each exercise will last an average of 5 to 7 minutes. These exercises have been developed in collaboration between the company providing the VR device and the rehabilitation teams. Patients will be set up by a healthcare provider in a dedicated room for VR use. The provider will configure the device, assist the patient in donning it, and initiate the program, will remain present throughout the session to monitor for any adverse effect~. While the specific exercises may vary, the total duration of the session will be 20 minutes, consisting of various exercises interspersed with breaks. The principal investigator will propose a standardized series of exercises,
Study: NCT06724627

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Dermatology/Skin - Other
Description: Belle AI for skin image assessment.
Study: NCT06722508

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise and nutritional prehabilitation
Description: The study involves a behavioral intervention (exercise and nutritional prehabilitation) designed to assess outcomes related to feasibility, acceptability, and safety in head and neck cancer patients. Outcomes are being measured following the intervention over a defined period (from diagnosis through 1-month post-surgery).
Study: NCT06724237

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous Hematopoietic Stem Cell Transplantation
Description: Undergo ASCT

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care observation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High Dose Chemotherapy
Description: Receive high dose chemotherapy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study: NCT06571773

Intervention type: PROCEDURE
Intervention: intraoperative implantation of Capsular Tension Ring
Description: The Capsular Tension Ring(ACPi-11; Bausch + Lomb, Rochester, New York, USA) is a device made of PMMA with blunt-tipped eyelets at its ends. It can be inserted at any point during cataract surgery, following the creation of a strong anterior capsulotomy via capsulorhexis
Study: NCT06724237

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stem Cell Mobilization Therapy
Description: Receive stem cell mobilization therapy
Study: NCT05300789

Intervention type: OTHER
Intervention: Follow-up
Description: There is no intervention. Patients are just going to be registered and oncologic follow-up data are going to be recorded.
Study: NCT06724393

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood flow restrictions in combination with low-intensity resistance training
Description: Blood flow restrictions in combination with low-intensity resistance training to test if an online intervention (telehealth) can improve functional capacity and balance in older adults

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blood flow restrictions in combination with low-intensity resistance training
Description: Blood flow restrictions in combination with low-intensity resistance training to test if an online intervention (telehealth) can improve functional capacity and balance in older adults
Study: NCT06724497

Intervention type: PROCEDURE
Group type: OTHER
Intervention: face scanning pre and post orthognathic surgery
Description: patient will be scanned pre operative using both scanners and then undergo orthognathic surgery then will be rescanned again 6 montsh later
Study: NCT06743646

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZVS101e
Description: subretinal injection of ZVS101e
Study: NCT05689554

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STOP Falls Educational Intervention
Description: This is a pragmatic, cluster-randomized, parallel-group, controlled clinical trial. The unit of randomization is the clinic, to avoid the risk of contamination if healthcare providers within a clinic were randomized (i.e., reducing the potential for intervention providers to communicate with control providers about the intervention and share materials). Eighteen clinics were identified for the trial, of which 9 were randomized to the intervention and 9 to usual care.
Study: NCT04920006

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhancing Active Caregiver Training
Description: The intervention has three components within each session. Step 1, View, involves group viewing of a caregiving scenario, developed during previous research, which portrays a situation in which a caregiver is dealing with a challenging behavioral symptom. Step 2, Practice, involves small-group rehearsal activities that facilitate understanding, making choices, and examining possible responses. Step 3, Reflect, involves self-reflection and group processing surrounding choices and observations.
Study: NCT06083038

Intervention type: DRUG
Intervention: Alpelisib
Description: Patients will receive standard of care alpelisib

Intervention type: DEVICE
Intervention: FreeStyle Libre 2 Continuous Glucose Monitor
Description: All patients will wear Abbott FreeStyle Libre 2 system to obtain CGM data (glucoses measured every minute for 14 days). CGM monitors will be placed at least 10 days prior to starting alpelisib and continue CGM for at least 3 months while taking alpelisib.
Study: NCT04991753

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo infusion will be administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nipocalimab
Description: Nipocalimab infusions will be administered intravenously.
Study: NCT06531798

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Breztri Aerosphere
Description: Budesonide 160 mcg/Glycopyrrolate 7.2 mcg/Formoterol fumarate dehydrate 5 mcg
Study: NCT06297629

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASTX727
Description: Given by PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASTX727
Description: Given by PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donor Lymphocyte Infusion
Description: Given by Infusion
Study: NCT04075903

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Storytelling
Description: A health literacy-appropriate and culturally-adapted intervention delivered on a tablet computer containing storytelling to improve patient gout knowledge and approaches to prevent flares, destigmatize gout, and enhance readiness to adopt available long-term treatments for gout including medications, diet, and exercise, or ii) usual gout care (control state).
Study: NCT06571773

Intervention type: PROCEDURE
Intervention: none intraoperative implantation of CTR
Description: the surgeon did a surgery without the intraoperative implantation of CTR
Study: NCT04983134

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced CHW Intervention
Description: community-based intervention
Study: NCT05934227

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 milligrams capsules plus metronidazole 400 milligrams
Description: supra and subgingival scaling and root planing (SRP) using manual and ultrasonic instruments in all residual pockets under anesthesia, performed within 2 consecutive days; systemic use of amoxicillin (500 milligrams) + metronidazole (400 milligrams) three times a day for 7 days after SRP

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: supra and subgingival scaling and root planing (SRP) using manual and ultrasonic instruments in all residual pockets under anesthesia, performed within 2 consecutive days; systemic use of placebo containing corn starch capsules three times a day for 7 days after SRP
Study: NCT06582797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: discontinuation of ART
Description: patient will discontinue their standard of care HIV treatment with ART while being closely monitored